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74 cases diagnosed to have brain tuberculoma
on the basis of clinical and CT Scan criteria
have been admitted to study in a 24 month period
from October, 1986. These cases were randomly
allocated to either Rif+INH+Pyrazinamide given
daily or thrice weekly for 3 months followed by
Rif and INH twice-weekly for a period of
6 months.
therapy and
The efficacy of short course chemo-
the serial CT Scan changes in rela-
tion to therapy are being evaluated in this
prospective study. A biopsy is done after
2 months of treatment if the scan does not show
20% reduction in size of the mass.
42 cases who had completed treatment and
followed up for 9 months after stopping treat-
ment form the population for the present interim
analysis. One third of the patients were less
than 15 years of age. 36% had multiple lesions.
The clinical presentation included focal con-
vulsions with or without localising signs and
signs of ICT.
Interim findings on clinical and scan findings
during,
for 18
end of chemotherapy and follow-up period
months will be presented and the results
appear encouraging.
